RT-104

N/A

Report date: 2023/03/10 14:59:17

Base Information

Drug NameRT-104
Drug Alias NameRT-104
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLiver Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Royaltech Med Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Royaltech Med Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLiver Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A